🇯🇵April 1, 2026·1d agoIndustry

GSK, Pfizer and Shionogi complete changes to ViiV Healthcare shareholding

Publisher

Shionogi (IR News)

Japan

This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.

Read original

In-platform summary, original article off-platform

This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.

Source route

Continue on shionogi.com

Leave the platform to read the original full article on the publisher site.

Source: Shionogi (IR News)

Scope: Industry

Open original article

Related coverage

More related coverage

Shionogi (IR News)·11h ago

Shionogi Completes Acquisition of All Rights to RADICAVA (edaravone)

Shionogi (IR News)·1d ago

Shionogi Announces Corporate Reorganization and Personnel Reassignment (Effective April 1, 2026)

Bristol Myers Squibb (Global)·8h ago

Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026

Us2.ai·11h ago

Apr 2, 2026How Us2.ai and Merge Are Bringing AI Echo Directly Into Clinical WorkflowsRepresentatives from Us2.ai and Merge sat down with the Cardiac Wire Show to discuss their new integration and what it means for the echo techs and cardiologists who use it everyday. Together, the two...